Our biomarkers can be used separately or in combination to reflect aberrant lung tissue remodeling, wound healing, and inflammation. The biomarkers have shown to be increased in progressive IPF patients and function as pharmacodynamic biomarkers.

More about our biomarkers for IPF

Find publications

Our tissue-derived Protein Fingerprint biomarkers can quantify structural tissue changes occurring in the lungs of patients with asthma. Our biomarkers are increased in asthmatic patients and are related to different subtypes.

More about our biomarkers for Asthma

Find publications

Our tissue-derived Protein Fingerprint biomarkers can quantify structural tissue changes occurring in the lungs of patients with COPD. Our biomarkers are related to disease activity in COPD patients and are successfully able to predict mortality.

More about our biomarkers for COPD

Find publications

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information. This is done in order to provide the best possible experience for the visitor. Cookie policy Privacy statement